Table 3 Association of new lipoprotein phenotypes with ASCVD risk factors in MESA

Phenotypes

Number

Mean Age

p = 0.0049

Mean BMI

P < 0.0001

Mean SBP

P = 0.0011

Mean CRP

P = 0.0097

N_L

246

63 (54–72)

A

28 (23.9–32.1)

C

124 (109–140)

D

3.8 (1.8–5.8)

BC

N_M

4632

62 (53–71)

A

28 (24.7–31.4)

C

126 (112–141)

CD

3.7 (2.0–5.3)

C

N_H

424

62 (54–69)

ABC

28.5 (25.5–31.5)

BC

127 (113–140)

BCD

3.3 (1.7–4.9)

C

IIa

91

62 (53–70)

ABC

27.7 (24.9–30.6)

C

126 (111–141)

ABCD

3.4 (1.6–5.2)

BC

IIb

177

62 (54–69)

ABC

29.4 (26.5–32.3)

AB

129 (115–143)

ABC

3.7 (2.1–5.3)

BC

IVa

144

62 (54–70)

AB

30 (27.2–32.9)

A

132 (117–146)

A

5.2 (2.1–8.4)

A

IVb

1040

61 (53–69)

BC

29.4 (26.3–32.5)

A

129 (115–142)

AB

4.2 (2.4–5.9)

BC

V

34

58 (53–63)

C

29.1 (25.8–32.4)

ABC

131 (116–147)

ABCD

4 (1.6–6.3)

ABC

Level

Number

%AA

P < 0.0001

% with diabetes

P < 0.0001

% on BP meds

p < 0.0001

% with Metabolic Syndrome

p < 0.0001

% of Smokers

p = 0.0002

N_L

246

41.1%

A

31.7%

BC

49.6%

A

31.7%

D

19.9%

AB

N_M

4632

31.0%

B

23.1%

D

36.4%

D

24.7%

E

13.5%

C

N_H

424

31.1%

B

23.6%

D

29.0%

E

26.4%

DE

15.8%

BC

IIa

91

39.6%

AB

28.6%

CD

23.1%

E

25.3%

DE

15.4%

BC

IIb

177

11.3%

CD

39.0%

BC

40.1%

BCD

76.3%

BC

16.9%

BC

IVa

144

20.8%

C

40.3%

B

49.3%

AB

84.7%

AB

20.1%

AB

IVb

1040

11.3%

D

36.1%

BC

40.2%

C

76.8%

C

17.1%

B

V

34

14.7%

CD

67.6%

A

41.2%

ABCDE

94.1%

A

32.4%

A

Level

Number

% Male

p = 0.3353

N_L

246

46.3%

A

N_M

4632

46.5%

A

N_H

424

46.9%

A

IIa

91

42.9%

A

IIb

177

46.9%

A

IVa

144

48.6%

A

IVb

1040

50.9%

A

V

34

52.9%

A